Presence & RecognitionEvent: September 8, 2026
Pyxis Oncology is excited to announce Thomas Civik as a new employee.
Published
Signal category
Presence & Recognition
Quote
“Congratulations, Thomas Civik! We're equally excited and looking forward to the next chapter at #PYXS”
— Nelson Azoulay|Pyxis Oncology team
Company
Pyxis Oncology
Charting a course to therapeutics for difficult-to-treat cancer.
- Industry
- Biotechnology Research
- Location
- Boston, US
- Company size
- 66 employees
Pyxis Oncology is transforming the lives of patients with cancer by advancing our differentiated portfolio of biologics that specifically target tumor cells and overcome immune suppression. We believe that antibody-drug conjugates (ADCs) and immunotherapies have the potential to address difficult-to-treat cancers and improve patient outcomes.
Founded 2019